Sign in to edit your profile (add interests, mentoring, photo, etc.)

    June Chan, DSc

    SchoolUCSF School of Medicine
    DepartmentEpidemiology & Biostatistics
    Address550 16th Street
    San Francisco CA 94158
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Harvard CollegeABApplied Math in Biology1994
      Harvard School of Public HealthScDEpidemiology1998
      Harvard School of Public HealthPost-doctoral Fellowship Epidemiology2000
      Collapse Awards and Honors
      Dept. of Urology, UCSF2009Steven & Christine Burd-Safeway Distinguished Professorship
      American Association for Cancer Research & CA Dept. of Health Services2002 - 2003Early Career Investigator Award
      Prostate Cancer Foundation (formerly CaPCURE)1998 - 2000Young Investigator Award
      Society for Epidemiologic Research1998Abraham Lilienfeld Student Prize
      Harvard University1996 - 1997Pforzheimer Public Service Fellowship
      Uppsala University, Sweden1994 - 1995Fulbright Scholar

      Collapse Overview 
      Collapse Overview
      Dr. June M. Chan has broad interests in cancer prevention and public health, in particular what individuals can do to modify their risk of chronic disease, co-morbidity, and death. She has expertise and interests in epidemiology and medical education; and has conducted research on diabetes, pancreatic, colon, and prostate cancer.

      Her current research is focused on understanding how diet, exercise, hormones, and genetics contribute to prostate cancer incidence, progression, and death. She is particularly interested in identifying modifiable lifestyle risk factors for prostate cancer progression, and using this information to help us better understand prostate cancer biology as well as inform public health guidelines. She has worked in this area for 15+ years and was awarded the Steven & Christine Burd-Safeway Distinguished Professorship at UCSF (University of California San Francisco) in 2009 in recognition of her teaching, research, and service activities in the field of prostate cancer. The goals of her clinical and translational research studies are to identify risk-reduction strategies for men with or at high risk for prostate cancer; evaluate novel molecular markers of prostate cancer aggressiveness that may improve screening, diagnosis, or prognosis of clinically relevant disease; and improve cancer survivorship for the millions of men living with prostate cancer worldwide.

      She is PI of the prospective national Diet and Lifestyle Study within the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), and a multi-site clinic-based cohort study examining nutritional and genetic risk factors for aggressive prostate cancer. She also collaborates with colleagues at the Harvard School of Public Health on the Health Professionals Follow-up Study to examine diet and lifestyle risk factors for prostate cancer progression, metastases, and death.

      Prior Training:
      1994 AB Applied Mathematics in Biology, Harvard College
      1994-95 Fulbright Scholar, Cancer Epidemiology Unit, Uppsala University, Sweden
      1998 ScD Epidemiology, Harvard School of Public Health

      Research Interest Keywords:
      - prostate cancer, cancer prevention, lifestyle risk factors, diet, physical activity, biomarkers, genetics, epidemiology, medical education, prognostication, public health, risk communication, health education & promotion, pancreatic cancer

      - Co-Director, Mechanisms, Methods, & Malignancy (M3), Essential Core Curriculum for Medical Students
      - Discipline Leader, Epidemiology and Evidence-Based Medicine, Essential Core Curriculum for Medical Students
      - Steering Committee Member, PhD Program in Epidemiology and Translational Science, UCSF

      University Service
      - Executive Committee Member, Department of Epidemiology & Biostatistics, UCSF
      - Co-Director, Genitourinary Cancer Epidemiology & Population Science Program, Dept. of Urology, UCSF

      Collapse ORNG Applications 
      Collapse Websites
      Collapse In The News
      Collapse NIH Awarded Grants
      Collapse Clinical Trials
      Collapse Featured Videos

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Chan JM, Kenfield SA, Paciorek A, Platz EA, Giovannucci EL, Stampfer MJ. Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1638-40.
        View in: PubMed
      2. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014 Sep; 66(3):550-60.
        View in: PubMed
      3. Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR. Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):165-9.
        View in: PubMed
      4. Chan JM, Gong Z, Holly EA, Bracci PM. Dietary patterns and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Nutr Cancer. 2013; 65(1):157-64.
        View in: PubMed
      5. Chan JM, Litwack-Harrison S, Bauer SR, Daniels NA, Wilt TJ, Shannon J, Bauer DC. Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1886-8.
        View in: PubMed PMC3489270
      6. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):211.
        View in: PubMed
      7. Richman EL, Chan JM. Selenium and prostate cancer: the puzzle isn't finished yet. Am J Clin Nutr. 2012 Jul; 96(1):1-2.
        View in: PubMed PMC3374730
      8. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60.
        View in: PubMed
      9. Aggarwal RR, Ryan CJ, Chan JM. Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? Urol Oncol. 2013 Jul; 31(5):522-30.
        View in: PubMed
      10. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50.
        View in: PubMed PMC3002170
      11. Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol. 2009 Aug 1; 27(22):3577-83.
        View in: PubMed PMC2720077
      12. Chan JM, Wang F, Holly EA. Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control. 2009 Aug; 20(6):835-46.
        View in: PubMed PMC2694313
      13. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst. 2008 Feb 6; 100(3):170-83.
        View in: PubMed
      14. Kenfield SA, Chang ST, Chan JM. Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer. Curr Treat Options Oncol. 2007 Jun; 8(3):173-96.
        View in: PubMed
      15. Shannon J, Shikany JM, Barrett-Connor E, Marshall LM, Bunker CH, Chan JM, Stone KL, Orwoll E. Demographic factors associated with the diet quality of older US men: baseline data from the Osteoporotic Fractures in Men (MrOS) study. Public Health Nutr. 2007 Aug; 10(8):810-8.
        View in: PubMed
      16. Bogen KT, Keating GA, Chan JM, Paine LJ, Simms EL, Nelson DO, Holly EA. Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans. Prostate Cancer Prostatic Dis. 2007; 10(3):261-9.
        View in: PubMed
      17. Chan JM, Feraco A, Shuman M, Hernández-Díaz S. The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs. Hematol Oncol Clin North Am. 2006 Aug; 20(4):797-809.
        View in: PubMed
      18. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 Dec; 66(6):1223-8.
        View in: PubMed
      19. Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control. 2005 Sep; 16(7):789-97.
        View in: PubMed
      20. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr. 2001 Oct; 74(4):549-54.
        View in: PubMed
      21. Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, Stampfer MJ. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst. 2001 Sep 5; 93(17):1330-6.
        View in: PubMed
      22. Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev. 2001; 23(1):87-92.
        View in: PubMed
      23. Chan JM, Giovannucci EL. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev. 2001; 23(1):82-6.
        View in: PubMed
      24. Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, Virtamo J. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control. 2000 Oct; 11(9):859-67.
        View in: PubMed
      25. Chan JM, Stampfer MJ, Giovannucci E, Ma J, Pollak M. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S32-3.
        View in: PubMed
      26. Ma J, Pollak M, Giovannucci E, Chan JM, Tao Y, Hennekens C, Stampfer MJ. A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S28-9.
        View in: PubMed
      27. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev. 1999 Oct; 8(10):893-9.
        View in: PubMed
      28. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999 Apr 7; 91(7):620-5.
        View in: PubMed
      29. Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden) Cancer Causes Control. 1998 Dec; 9(6):559-66.
        View in: PubMed
      30. Chan JM, Stampfer MJ, Giovannucci EL. What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol. 1998 Aug; 8(4):263-73.
        View in: PubMed
      31. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998 Jan 23; 279(5350):563-6.
        View in: PubMed
      32. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995 Mar 4; 310(6979):555-9.
        View in: PubMed PMC2548937
      33. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994 Sep; 17(9):961-9.
        View in: PubMed
      June's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP